Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Quest to beat the US saw a Chinese team turn to ancient traditions, leading to a new technique 10 times more effective than ...

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

Beam stock launched Monday after the company reached a deal with the Food and Drug Administration for its gene-editing drug, ...

A baby who is the first patient in the world to be successfully treated with customized CRISPR gene editing therapy is finally returning home from the hospital. Nine-month-old KJ Muldoon of Clifton ...

Thanks to genetic science, gene editing, and techniques like cloning, it’s now possible to move DNA through time, studying ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...